Caligan Partners将支持以每股至少3美元的价格出售该公司。潜在的购买方可能包括CSL Behring(OTCPK:CSLY)、Grifols(纳斯达克:GRFS)、武田夏尔和Octaharma。私募股权机构也可能对公司感兴趣。
查看全文
智通财经APP了解到,低价股虽然波动很大,但可能成为投资组合中有吸引力的补充部分。 尽管今年美股大幅下滑,但一些低价生物科技股实现了三位数涨幅。具体如下: ADMA Biologics 对ADMA Biologics(ADMA.US)来说,今年是丰收的一年,其股... 网页链接
$ADMA Biologics(ADMA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-24-032245 Size: 8 KB 网页链接
$ADMA Biologics(ADMA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-24-032247 Size: 6 KB 网页链接
$ADMA Biologics(ADMA)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001140361-24-031778 Act: 34 Size: 413 KB 网页链接
$ADMA Biologics(ADMA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-24-030232 Size: 12 KB 网页链接
$ADMA Biologics(ADMA)$ 144 Report of proposed sale of securities Accession Number: 0001140361-24-030218 Act: 33 Size: 4 KB 网页链接
$ADMA Biologics(ADMA)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001140361-24-028800 Act: 34 Size: 174 KB 网页链接
$ADMA Biologics(ADMA)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001140361-24-026601 Act: 34 Size: 5 MB 网页链接
$ADMA Biologics(ADMA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001140361-24-025226 Act: 34 Size: 7 MB 网页链接
$ADMA Biologics(ADMA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001140361-24-025173 Act: 34 Size: 442 KB 网页链接
$ADMA Biologics(ADMA)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001140361-24-019869 Act: 34 Size: 2 MB 网页链接